A novel high-prevalence antigen in the Lutheran system, LUGA (LU24), and an updated, full-length 3D BCAM model

Aline Floch1,2,3, Christine Lomas-Francis3, Sunitha Vege3

  • 1Univ Paris Est Creteil, INSERM U955 Equipe Transfusion et maladies du globule rouge, IMRB, Creteil, France.

Transfusion
|February 4, 2023
PubMed

Insights

Researchers identified a novel Lutheran antigen (LUGA) on basal cell adhesion molecule (BCAM) and developed an updated 3D model. This model aids in understanding antigen expression and evaluating new genetic variations.

Area of Science:

  • Immunogenetics
  • Molecular Biology
  • Structural Biology

Background:

  • Basal cell adhesion molecule (BCAM) encodes antigens for the Lutheran (LU) blood group system.
  • BCAM plays a crucial role in red blood cell antigen expression and immune responses.

Purpose of the Study:

  • To report a novel Lutheran antigen and its association with BCAM.
  • To develop an updated, full-length 3D structural model of BCAM.
  • To analyze the impact of genetic variations on Lutheran antigen expression.

Main Methods:

  • Standard red blood cell testing and antibody identification.
  • Genomic DNA sequencing of BCAM.
  • Multi-template homology modeling for BCAM structure prediction.
  • Analysis of residue accessibility for variant proteins.

Main Results:

  • A novel Lutheran antigen, LUGA (LU24), was identified.
  • Sequencing revealed three homozygous changes in BCAM, including c.212G>A (p.Arg71His), leading to LUGA antigen loss.
  • An updated 3D model of BCAM was constructed, showing most antigen-associated residues are exposed.

Conclusions:

  • The identified BCAM variant c.212G>A causes the loss of the LUGA (LU24) antigen.
  • The new BCAM model and exposed residue data will aid in assessing the immunogenicity of novel polymorphisms.
Abstract